Emcure Pharmaceuticals reported a strong first quarter with a 41% increase in net profit, reaching Rs 215 crore, and a 16% rise in revenue to Rs 2,101 crore. Growth was fueled by robust domestic and international performance, particularly in the rest of the world and Canada.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets